Cincinnati, Ohio-based Chemed Corp. said its board authorized an additional $150 million for stock repurchase under the company's existing share repurchase program.
The repurchases will be funded through a combination of cash generated from operations as well as utilization of the company's revolving credit facility.
Chemed's board previously approved an additional $100 million for the stock repurchase program in March 2017.
